Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligand

Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligand

US Patent 12479904 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating cancer using soluble forms of PSGL-1 and fusion molecules t2025
Variants of IgG Fc with limited amine groups2019
Variants of IgG-Fc fusion that provide for site-specific conjugation at the N-te2019
Compositions and methods for treatment of thrombosis and for prolonging survival2016
Soluble tandem selectin glycoprotein ligand molecules2014
P-selectin ligand protein2012
Nucleic acids encoding P-selectin ligand fusion proteins2011
Platelet glycoprotein Ib alpha variant fusion polypeptides and methods of use th2010
P-selectin ligand protein2009
Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligan2008
Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding sam2007
Platelet glycoprotein Ibα fusion polypeptides and methods of use thereof2006